Patents | Published:

Patent mining and landscaping of emerging recombinant factor VIII through network analysis

Nature Biotechnology volume 36, pages 585590 (2018) | Download Citation

A landscape analysis of the recombinant factor VIII patent sector using network analysis to map the cooperation network among assignees shows emerging technologies that focus on improved methods for rFVIII production and bioactivity performance.

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

  1. 1.

    et al. Haemophilia 19, e1–e47 (2013).

  2. 2.

    et al. J. Thromb. Haemost. 11, 670–678 (2013).

  3. 3.

    et al. Blood 126, 1078–1085 (2015).

  4. 4.

    et al. Blood 123, 317–325 (2014).

  5. 5.

    et al. Thromb. Res. 132, 280–287 (2013).

  6. 6.

    et al. Blood 127, 1633–1641 (2016).

  7. 7.

    & Thromb. Res. 141 Suppl 3, S1 (2016).

  8. 8.

    & Res. Policy 35, 463–480 (2006).

  9. 9.

    , & Sci. Public Policy 39, 751–760 (2012).

  10. 10.

    & Innov. Manag. Policy Pract. 12, 5–17 (2010).

  11. 11.

    Rand J. Econ. 21, 172–187 (1990).

  12. 12.

    & Patents, Citations & Innovations: a Window on the Knowledge Economy (MIT, 2002).

  13. 13.

    Scientometrics 30, 147–155 (1994).

  14. 14.

    World Pat. Inf. 19, 269–272 (1997).

  15. 15.

    Adv. Complex Syst. 10, 93–115 (2007).

  16. 16.

    , & Econ. Innov. New Technol. 18, 311–336 (2009).

  17. 17.

    , & in Economia de Baixo Carbono: Impactos de Novos Marcos Regulatórios e Tecnológicos sobre a Economia Brasileira, (eds. Toneto, Jr., R. & Pinho, M.) 452 (FUNPEC-Editora, 2017).

  18. 18.

    et al. Nat. Biotechnol. 32, 742–748 (2014).

  19. 19.

    , , & Nat. Biotechnol. 34, 1025–1031 (2016).

  20. 20.

    & CEPR Discussion Paper No. 6178. (2007).

  21. 21.

    , & Top. Econ. Anal. Policy 4, 1–48 (2004).

  22. 22.

    World Federation of Hemophilia. World Federation of Hemophilia Report on the Annual Global Survey 2014 (World Federation of Hemophilia, 2015).

  23. 23.

    & in 2015 International Conference on Futuristic Trends on Computational Analysis and Knowledge Management (ABLAZE) 510–514 (IEEE, 2015).

  24. 24.

    et al. Blood 119, 3024–3030 (2012).

  25. 25.

    et al. Nat. Biotechnol. 27, 1186–1190 (2009).

  26. 26.

    et al. Blood 126, 3492 (2015).

  27. 27.

    et al. Scientometrics 95, 225–242 (2013).

  28. 28.

    & Soc. Networks 11, 39–63 (1989).

  29. 29.

    et al. Blood 109, 546–551 (2007).

  30. 30.

    & Haemophilia 22 Suppl 5, 25–30 (2016).

Download references

Acknowledgements

This study is supported by research funds from São Paulo Research Foundation – FAPESP grant number 2012/22686-9; 2014/22500-8; 2015/13816-4; 2013/08135-2 and 2016/02433-0.

Author information

Affiliations

  1. School of Economics, Business Administration and Accounting, University of São Paulo, Ribeirão Preto, São Paulo, Brazil.

    • Cristiano Gonçalves Pereira
    •  & Geciane Silveira Porto
  2. Center for Cell-based Therapy CTC, Regional Blood Center of Ribeirão Preto, University of São Paulo. Ribeirão Preto, São Paulo, Brazil.

    • Virgínia Picanco-Castro
    •  & Dimas Tadeu Covas
  3. Institute of Advanced Studies of the University of São Paulo IEA/USP, Ribeirão Preto, São Paulo, Brazil.

    • Geciane Silveira Porto

Authors

  1. Search for Cristiano Gonçalves Pereira in:

  2. Search for Virgínia Picanco-Castro in:

  3. Search for Dimas Tadeu Covas in:

  4. Search for Geciane Silveira Porto in:

Competing interests

The authors declare no competing financial interests.

Corresponding author

Correspondence to Geciane Silveira Porto.

Supplementary information

PDF files

  1. 1.

    Supplementary Text and Figures

    Supplementary Figures 1–4, Supplementary Tables 1–3 and Supplementary Methods

About this article

Publication history

Published

DOI

https://doi.org/10.1038/nbt.4178

Newsletter Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing